Blocking carbohydrate absorption and weight loss: a clinical trial using the phase 2® brand proprietary fractionated white bean extract

Completed

• Conditions: Overweight; Nutritional, Metabolic, Endocrine; Obesity

• Registration Number: ISRCTN87421612
• Lead Sponsor: Pharmachem Laboratories

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2004-12-08
• Last Update Posted: 2015-01-13

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 0

Inclusion Criteria

1. Aged over 18 and under 40 at screening
2. Body Mass Index (BMI) more than or equal to 23kg/m^2 and less than 31 kg/m^2 at screening
3. Agreement to maintain diet, exercise and behavioral modification guidelines while participating in the study
4. Agreement to periodic follow-up
5. Females agreement to use appropriate birth control methods during the active study

Exclusion Criteria

1. Use of any drugs, herbs or other non-prescription preparations for obesity within four weeks of screening including, but not limited to, Sibutramine, Orlistat, Phen-Fen, Metabolife, diuretics etc
2. Abnormal electrocardiogram (EKG), Complete Blood Count (CBC), metabolic panel, or physical examination
3. An active eating disorder
4. Severe hepatic or renal disease
5. History of seizure, alcohol abuse, chronic malabsorption, diverticulosis or diverticulitis
6. Diagnosis of coronary artery disease, congestive heart failure, stroke, arrhythmia, or uncontrolled hypertension
7. Pregnancy or lactation
8. Inability to understand or follow the study protocol
9. Diagnosis of significant psychiatric disease or depression
10. Known sensitivities to the product

Study & Design

• Study Type: Interventional
• Study Design: Not specified